论文信息 - A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease - 字舞流文

A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease

Xi Chen | Ying Sun | Jian Wang | Lin Wang | Yongxiang Yi | YongChen Zhang | Zheng Fu | Zhen Zhou | Xingxiang Liu | Xinyi Xia | Chen-Yu Zhang | Zheng Wang | Jian Wu | Likun Zhou

[1] Xiuyong Li,et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 , 2020, Journal of medical virology.

[2] X. Zou,et al. An overview of RNA virus-encoded microRNAs , 2019, ExRNA.

[3] Hongwei Liang,et al. H5N1 influenza virus-specific miRNA-like small RNA increases cytokine production and mouse mortality via targeting poly(rC)-binding protein 2 , 2018, Cell Research.

[4] Ruifu Yang,et al. Pluripotency-associated miR-290/302 family of microRNAs promote the dismantling of naive pluripotency , 2016, Cell Research.

[5] S. Asgari,et al. MicroRNA-like viral small RNA from Dengue virus 2 autoregulates its replication in mosquito cells , 2014, Proceedings of the National Academy of Sciences.

[6] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[7] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.